PIRAMAL PHARMA
|
PIRAMAL PHARMA Last 5 Year Income Statement History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|
INCOME : | ||||
Gross Sales | ₹9,421 Cr | ₹8,107 Cr | ₹7,306 Cr | ₹7,003 Cr |
Sales | ₹8,316 Cr | ₹7,014 Cr | ₹6,324 Cr | ₹6,058 Cr |
Job Work/ Contract Receipts | - | - | - | - |
Processing Charges / Service Income | ₹1,040 Cr | ₹1,043 Cr | ₹854 Cr | ₹901 Cr |
Revenue from property development | - | - | - | - |
Other Operational Income | ₹65 Cr | ₹49 Cr | ₹128 Cr | ₹45 Cr |
Less: Excise Duty | - | - | - | - |
Net Sales | ₹8,171 Cr | ₹7,082 Cr | ₹6,559 Cr | ₹6,315 Cr |
EXPENDITURE : | ||||
Increase/Decrease in Stock | ₹-199 Cr | ₹69 Cr | ₹55 Cr | ₹-53 Cr |
Raw Material Consumed | ₹3,153 Cr | ₹2,635 Cr | ₹2,396 Cr | ₹2,112 Cr |
Opening Raw Materials | ₹728 Cr | ₹599 Cr | ₹449 Cr | ₹178 Cr |
Purchases Raw Materials | ₹2,270 Cr | ₹1,812 Cr | ₹1,717 Cr | ₹1,617 Cr |
Closing Raw Materials | ₹1,022 Cr | ₹728 Cr | ₹599 Cr | ₹449 Cr |
Other Direct Purchases / Brought in cost | ₹1,176 Cr | ₹952 Cr | ₹829 Cr | ₹594 Cr |
Other raw material cost | - | - | - | ₹172 Cr |
Power & Fuel Cost | ₹242 Cr | ₹208 Cr | ₹164 Cr | ₹137 Cr |
Electricity & Power | ₹242 Cr | ₹208 Cr | ₹164 Cr | ₹137 Cr |
Oil, Fuel & Natural gas | - | - | - | - |
Coals etc | - | - | - | - |
Other power & fuel | - | - | - | - |
Employee Cost | ₹2,030 Cr | ₹1,896 Cr | ₹1,589 Cr | ₹1,468 Cr |
Salaries, Wages & Bonus | ₹1,724 Cr | ₹1,642 Cr | ₹1,368 Cr | ₹1,241 Cr |
Contributions to EPF & Pension Funds | ₹130 Cr | ₹115 Cr | ₹102 Cr | ₹98 Cr |
Workmen and Staff Welfare Expenses | ₹143 Cr | ₹136 Cr | ₹115 Cr | ₹123 Cr |
Other Employees Cost | ₹33 Cr | ₹3.64 Cr | ₹3.81 Cr | ₹5.12 Cr |
Other Manufacturing Expenses | ₹732 Cr | ₹674 Cr | ₹589 Cr | ₹544 Cr |
Sub-contracted / Out sourced services | - | - | - | - |
Processing Charges | ₹19 Cr | ₹23 Cr | ₹12 Cr | ₹11 Cr |
Repairs and Maintenance | ₹308 Cr | ₹268 Cr | ₹220 Cr | ₹187 Cr |
Packing Material Consumed | - | - | - | - |
Other Mfg Exp | ₹405 Cr | ₹383 Cr | ₹357 Cr | ₹345 Cr |
General and Administration Expenses | ₹542 Cr | ₹473 Cr | ₹428 Cr | ₹367 Cr |
Rent , Rates & Taxes | ₹121 Cr | ₹89 Cr | ₹102 Cr | ₹74 Cr |
Insurance | ₹46 Cr | ₹44 Cr | ₹43 Cr | ₹37 Cr |
Printing and stationery | ₹42 Cr | ₹43 Cr | ₹45 Cr | ₹7.82 Cr |
Professional and legal fees | ₹202 Cr | ₹174 Cr | ₹136 Cr | ₹122 Cr |
Traveling and conveyance | ₹77 Cr | ₹66 Cr | ₹35 Cr | ₹22 Cr |
Other Administration | ₹53 Cr | ₹57 Cr | ₹68 Cr | ₹104 Cr |
Selling and Distribution Expenses | ₹360 Cr | ₹373 Cr | ₹318 Cr | ₹250 Cr |
Advertisement & Sales Promotion | ₹142 Cr | ₹176 Cr | ₹151 Cr | ₹103 Cr |
Sales Commissions & Incentives | ₹7.70 Cr | ₹3.01 Cr | - | - |
Freight and Forwarding | ₹154 Cr | ₹145 Cr | ₹133 Cr | ₹110 Cr |
Handling and Clearing Charges | ₹56 Cr | ₹49 Cr | ₹32 Cr | ₹35 Cr |
Other Selling Expenses | - | - | ₹1.18 Cr | ₹2.25 Cr |
Miscellaneous Expenses | ₹142 Cr | ₹126 Cr | ₹70 Cr | ₹62 Cr |
Bad debts /advances written off | ₹26 Cr | - | - | - |
Provision for doubtful debts | ₹31 Cr | ₹42 Cr | ₹8.60 Cr | - |
Losson disposal of fixed assets(net) | ₹0.46 Cr | ₹0.48 Cr | ₹0.54 Cr | - |
Losson foreign exchange fluctuations | - | - | - | - |
Losson sale of non-trade current investments | - | - | - | - |
Other Miscellaneous Expenses | ₹84 Cr | ₹84 Cr | ₹61 Cr | ₹62 Cr |
Less: Expenses Capitalised | - | - | - | - |
Total Expenditure | ₹7,001 Cr | ₹6,453 Cr | ₹5,609 Cr | ₹4,887 Cr |
Operating Profit (Excl OI) | ₹1,171 Cr | ₹628 Cr | ₹950 Cr | ₹1,428 Cr |
Other Income | ₹201 Cr | ₹225 Cr | ₹276 Cr | ₹164 Cr |
Interest Received | ₹12 Cr | ₹1.64 Cr | ₹0.68 Cr | ₹4.02 Cr |
Dividend Received | - | - | - | - |
Profit on sale of Fixed Assets | - | - | - | ₹1.14 Cr |
Profits on sale of Investments | ₹4.27 Cr | ₹1.58 Cr | ₹1.95 Cr | - |
Provision Written Back | ₹73 Cr | ₹49 Cr | ₹60 Cr | ₹6.74 Cr |
Foreign Exchange Gains | ₹30 Cr | ₹111 Cr | ₹17 Cr | ₹61 Cr |
Others | ₹82 Cr | ₹62 Cr | ₹196 Cr | ₹91 Cr |
Operating Profit | ₹1,372 Cr | ₹853 Cr | ₹1,225 Cr | ₹1,592 Cr |
Interest | ₹448 Cr | ₹344 Cr | ₹198 Cr | ₹163 Cr |
InterestonDebenture / Bonds | - | - | - | - |
Interest on Term Loan | - | - | - | - |
Intereston Fixed deposits | - | - | - | - |
Bank Charges etc | ₹1.54 Cr | ₹6.47 Cr | ₹9.47 Cr | ₹5.43 Cr |
Other Interest | ₹447 Cr | ₹338 Cr | ₹189 Cr | ₹158 Cr |
PBDT | ₹923 Cr | ₹509 Cr | ₹1,027 Cr | ₹1,429 Cr |
Depreciation | ₹741 Cr | ₹677 Cr | ₹586 Cr | ₹545 Cr |
Profit Before Taxation & Exceptional Items | ₹183 Cr | ₹-168 Cr | ₹441 Cr | ₹884 Cr |
Exceptional Income / Expenses | ₹-63 Cr | ₹-6.96 Cr | ₹-15 Cr | ₹18 Cr |
Profit Before Tax | ₹179 Cr | ₹-120 Cr | ₹485 Cr | ₹949 Cr |
Provision for Tax | ₹161 Cr | ₹66 Cr | ₹109 Cr | ₹114 Cr |
Current Income Tax | ₹190 Cr | ₹98 Cr | ₹191 Cr | ₹116 Cr |
Deferred Tax | ₹-24 Cr | ₹-44 Cr | ₹-82 Cr | ₹-2.32 Cr |
Other taxes | ₹-5.04 Cr | ₹12 Cr | - | - |
Profit After Tax | ₹18 Cr | ₹-186 Cr | ₹376 Cr | ₹835 Cr |
Extra items | - | - | - | - |
Minority Interest | - | - | - | - |
Share of Associate | - | - | - | - |
Other Consolidated Items | - | - | - | - |
Consolidated Net Profit | ₹18 Cr | ₹-186 Cr | ₹376 Cr | ₹835 Cr |
Adjustments to PAT | - | - | - | - |
Profit Balance B/F | ₹956 Cr | ₹1,159 Cr | ₹833 Cr | - |
Appropriations | ₹974 Cr | ₹972 Cr | ₹1,209 Cr | ₹835 Cr |
General Reserves | - | - | - | - |
Proposed Equity Dividend | - | - | - | - |
Corporate dividend tax | - | - | - | - |
Other Appropriation | ₹3.57 Cr | ₹16 Cr | ₹50 Cr | ₹2.47 Cr |
Equity Dividend % | ₹1.10 | - | - | - |
Earnings Per Share | ₹0.13 | ₹-1.56 | ₹3.17 | ₹8.40 |
Adjusted EPS | ₹0.13 | ₹-1.53 | ₹3.10 | ₹8.20 |
Compare Income Statement of peers of PIRAMAL PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
PIRAMAL PHARMA | ₹35,177.4 Cr | 0.8% | 2.3% | 83.1% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹451,603.0 Cr | 2.9% | 6.4% | 48.1% | Stock Analytics | |
DIVIS LABORATORIES | ₹160,862.0 Cr | 0.5% | -2.1% | 59.2% | Stock Analytics | |
CIPLA | ₹122,810.0 Cr | 2.3% | 1% | 20.6% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹114,946.0 Cr | 3.5% | 15.7% | 20.3% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹96,377.1 Cr | -0.1% | 2.3% | 41.1% | Stock Analytics |
PIRAMAL PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
PIRAMAL PHARMA | 0.8% |
2.3% |
83.1% |
SENSEX | 0.3% |
-2.5% |
10% |
You may also like the below Video Courses